Metraipolis › archive › dc_affa39cff79d

Association of Serum IL-35 and TGF-β Levels with the Incidence, Severity, and Treatment Response in Iraqi Patients with Graves' Disease — Europe PMC PMID:41099051

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41099051
DOI
10.30699/ijp.2025.2066164.3489
License (as archived)
solo-consultazione
Archived
2026-11-10T14:17:40.958Z
SHA-256 of the archived text
149bb0378762c462ad8da717a031f92baabec93cb1cdbeffb4828e232daff7fe
Stable URL of this page
https://metraipolis.com/documento/dc_affa39cff79d

How to cite

Association of Serum IL-35 and TGF-β Levels with the Incidence, Severity, and Treatment Response in Iraqi Patients with Graves' Disease — Europe PMC PMID:41099051 — Europe PMC (en), https://europepmc.org/article/MED/41099051 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_affa39cff79d (Metraipolis archive dc_affa39cff79d, sha256 149bb0378762c462ad8da717a031f92baabec93cb1cdbeffb4828e232daff7fe)
BibTeX
@misc{dcaffa39cff79d,
  title = {Association of Serum IL-35 and TGF-β Levels with the Incidence, Severity, and Treatment Response in Iraqi Patients with Graves' Disease — Europe PMC PMID:41099051},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41099051},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_affa39cff79d; sha256 149bb0378762c462ad8da717a031f92baabec93cb1cdbeffb4828e232daff7fe},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41099051. Agents can read the archived copy with the MCP tool read_document.